0
Viracta Therapeutics, Inc. Banner Image

Viracta Therapeutics, Inc.

  • Ticker VIRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Viracta Therapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in San Diego, California
Viracta is a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide. Their team possesses deep, cross-functional experience and shares a longstanding commitment to developing new medicines to benefit cancer patients. They are a precision oncology company focused on the treatment and prevention of virus-associated cancersMore that impact patients worldwide. Their lead product candidate is Nana-val, an all-oral combination therapy of their proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir.
REPORT RATINGS
4.7 / 5.0 (154)

Viracta Therapeutics, Inc. reports have an aggregate usefulness score of 4.7 based on 154 reviews.

Viracta Therapeutics, Inc.

Most Recent Annual Report

Viracta Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K
Add Annual Report To Cart

Older/Archived Annual Reports

Viracta Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!